Evidence map›Paper›PMID 16131422›Full record

ReviewCurrent neurology and neuroscience reports2005

Genetics of cerebral cavernous malformations.

Nicholas W Plummer, Jon S Zawistowski, Douglas A Marchuk

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 72 citations in OpenAlex.

  1. KRIT1 in vascular biology and beyond.Bioscience reports · 2024
    Review
  2. Article
  3. Hemorrhagic stroke in children.Journal of central nervous system disease · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Comparative omics of CCM signaling complex (CSC).Chinese neurosurgical journal · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  16. Review
  17. Article
  18. Review
  19. Observational
  20. Neurovascular development and links to disease.Cellular and molecular life sciences : CMLS · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nicholas W PlummerDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Box 3175, Durham, NC 27710, USA.
Jon S Zawistowski
Douglas A Marchuk
Duke Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The past few years have seen rapid advances in our understanding of the genetics and molecular biology of cerebral cavernous malformations (CCM). This article summarizes the recent cloning of the CCM1, CCM2, and CCM3 genes, which are responsible for autosomal dominant CCM, and also describes current hypotheses for their roles in integrin and p38 mitogen-activated protein kinase- mediated regulation of angiogenesis. A mouse model of CCM has been generated by mutation of the Ccm1 gene, and it indicates a role for that protein in arterial development. Future studies will probably focus on integration of data from each of the three CCM genes into a single model of the pathogenesis of cavernous malformation.

Indexed as

ApoptosisCarrier ProteinsCell ProliferationCerebellar DiseasesHumansIntracranial Arteriovenous MalformationsKRIT1 ProteinMicrotubule-Associated ProteinsModels, MolecularProto-Oncogene ProteinsCarrier ProteinsCCM2 protein, humanKRIT1 ProteinKRIT1 protein, humanMicrotubule-Associated ProteinsProto-Oncogene Proteins

Identifiers

PMID16131422
OpenAlexW2004022651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.